CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Revenue:
Revenue	$ 246,091	$ 131,612
Expenses:
Cost of sales	2,983	1,463
Research, development and patent	210,173	200,759
Selling, general and administrative	150,359	76,250
Total operating expenses	363,515	278,472
Loss from operations	(117,424)	(146,860)
Other income (expense):
Investment income	25,484	24,667
Interest expense	(5,160)	(4,108)
Interest expense related to sale of future royalties	(17,337)	(18,822)
Gain (loss) on investments, net	22,583	(2,164)
Other income (expense), net	(456)	465
Loss before income tax expense	(92,310)	(146,822)
Income tax expense	(218)	(116)
Net loss	$ (92,528)	$ (146,938)
Basic net loss per share (in Dollars per share)	$ (0.56)	$ (0.93)
Diluted net loss per share (in Dollars per share)	$ (0.56)	$ (0.93)
Shares used in computing basic net loss per share (in Shares)	164,874	158,735
Shares used in computing diluted net loss per share (in Shares)	164,874	158,735
Product Sales, Net [Member]
Revenue:
Revenue	$ 42,955	$ 6,287
Royalty Revenue [Member]
Revenue:
Revenue	58,323	64,166
Other Commercial Revenue [Member]
Revenue:
Revenue	6,532	5,715
Commercial Revenue [Member]
Revenue:
Revenue	107,810	76,168
Collaborative Agreement Revenue [Member]
Revenue:
Revenue	120,660	45,031
WAINUA Joint Development Revenue [Member]
Revenue:
Revenue	17,621	10,413
Research and Development Revenue [Member]
Revenue:
Revenue	$ 138,281	$ 55,444